Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 13, Issue 3, Pages 301-309
Publisher
Informa UK Limited
Online
2016-10-21
DOI
10.1080/17425255.2017.1251581
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimization of a novel series of pyranopyridine RND efflux pump inhibitors
- (2016) Zachary Aron et al. CURRENT OPINION IN MICROBIOLOGY
- A new Pseudomonas quinolone signal (PQS) binding partner: MexG
- (2016) James T. Hodgkinson et al. Chemical Science
- Efflux Pump Blockers in Gram-Negative Bacteria: The New Generation of Hydantoin Based-Modulators to Improve Antibiotic Activity
- (2016) Ewa Otręebska-Machaj et al. Frontiers in Microbiology
- A Transporter Interactome Is Essential for the Acquisition of Antimicrobial Resistance to Antibiotics
- (2016) Yonatan Shuster et al. PLoS One
- The pseudo-atomic structure of an RND-type tripartite multidrug efflux pump
- (2015) Dijun Du et al. BIOLOGICAL CHEMISTRY
- Structure–activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors
- (2015) Son T. Nguyen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
- (2015) Xian-Zhi Li et al. CLINICAL MICROBIOLOGY REVIEWS
- Prevalence of eight resistance-nodulation-division efflux pump genes in epidemiologically characterized Acinetobacter baumannii of worldwide origin
- (2015) Jennifer Nowak et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Microspectrometric insights on the uptake of antibiotics at the single bacterial cell level
- (2015) Bertrand Cinquin et al. Scientific Reports
- Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
- (2015) Jürg Dreier et al. Frontiers in Microbiology
- RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition
- (2015) Henrietta Venter et al. Frontiers in Microbiology
- Recent advances toward a molecular mechanism of efflux pump inhibition
- (2015) Timothy J. Opperman et al. Frontiers in Microbiology
- Structural basis of RND-type multidrug exporters
- (2015) Akihito Yamaguchi et al. Frontiers in Microbiology
- Bacterial Multidrug Efflux Transporters
- (2014) Jared A. Delmar et al. Annual Review of Biophysics
- Expression of homologous RND efflux pump genes is dependent upon AcrB expression: implications for efflux and virulence inhibitor design
- (2014) Jessica M. A. Blair et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Intra-abdominal Infections: Etiology, Epidemiology, Microbiological Diagnosis and Antibiotic Resistance
- (2014) G. Nicoletti et al. JOURNAL OF CHEMOTHERAPY
- Structure of the AcrAB–TolC multidrug efflux pump
- (2014) Dijun Du et al. NATURE
- Molecular mechanisms of antibiotic resistance
- (2014) Jessica M. A. Blair et al. NATURE REVIEWS MICROBIOLOGY
- Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening and In Vitro Validation
- (2014) Vasudevan Aparna et al. PLoS One
- Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump
- (2014) Thelma Ohene-Agyei et al. MicrobiologyOpen
- RND Efflux Pumps: Structural Information Translated into Function and Inhibition Mechanisms
- (2013) Paolo Ruggerone et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Interplay between Three RND Efflux Pumps in Doxycycline-Selected Strains of Burkholderia thailandensis
- (2013) Fabrice Vincent Biot et al. PLoS One
- Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin
- (2012) Jadwiga Handzlik et al. BIOORGANIC & MEDICINAL CHEMISTRY
- RND type efflux pump system MexAB-OprM of pseudomonas aeruginosa selects bacterial languages, 3-oxo-acyl-homoserine lactones, for cell-to-cell communication
- (2012) Shu Minagawa et al. BMC MICROBIOLOGY
- Efflux Pumps of Gram-Negative Bacteria, a New Target for New Molecules
- (2012) Jean-Marie Pages et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae
- (2012) Wakano Ogawa et al. GENE
- Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations
- (2012) A. V. Vargiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance
- (2012) E. C. Hobbs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amine–alkyl derivatives of hydantoin: New tool to combat resistant bacteria
- (2011) Jadwiga Handzlik et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria
- (2011) Jean-Michel Bolla et al. FEBS LETTERS
- Quorum Sensing in Gram-Negative Bacteria: Small-Molecule Modulation of AHL and AI-2 Quorum Sensing Pathways
- (2010) Warren R. J. D. Galloway et al. CHEMICAL REVIEWS
- Managing antimicrobial resistance in intensive care units
- (2010) Tejal N. Gandhi et al. CRITICAL CARE MEDICINE
- Progress and Challenges in Implementing the Research on ESKAPE Pathogens
- (2010) Louis B. Rice INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains
- (2010) Jacqueline Chevalier et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Does the Wide Use of Quaternary Ammonium Compounds Enhance the Selection and Spread of Antimicrobial Resistance and Thus Threaten Our Health?
- (2010) Kristin Hegstad et al. Microbial Drug Resistance
- An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates
- (2010) A. Mahamoud et al. MICROBIOLOGY-SGM
- Quorum sensing in bacterial virulence
- (2010) L. C. M. Antunes et al. MICROBIOLOGY-SGM
- The antibacterial lead discovery challenge
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli
- (2010) Y. Takatsuka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Geraniol Restores Antibiotic Activities against Multidrug-Resistant Isolates from Gram-Negative Species
- (2009) V. Lorenzi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The clinical consequences of antimicrobial resistance
- (2009) Louis B Rice CURRENT OPINION IN MICROBIOLOGY
- Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update
- (2009) Jessica MA Blair et al. CURRENT OPINION IN MICROBIOLOGY
- Quorum sensing and social networking in the microbial world
- (2009) S. Atkinson et al. Journal of the Royal Society Interface
- Synergistic interaction of eugenol with antibiotics against Gram negative bacteria
- (2009) S. Hemaiswarya et al. PHYTOMEDICINE
- A coordinated network of transporters with overlapping specificities provides a robust survival strategy
- (2009) N. Tal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RamA Confers Multidrug Resistance in Salmonella enterica via Increased Expression of acrB, Which Is Inhibited by Chlorpromazine
- (2008) A. M. Bailey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria
- (2008) Jean-Marie Pagès et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps
- (2008) L. Amaral et al. CURRENT DRUG TARGETS
- New Methods for the Identification of Efflux Mediated MDR Bacteria, Genetic Assessment of Regulators and Efflux Pump Constituents, Characterization of Efflux Systems and Screening for Inhibitors of Efflux Pumps
- (2008) M. Viveiros et al. CURRENT DRUG TARGETS
- Membrane Permeability and Regulation of Drug “Influx and Efflux” in Enterobacterial Pathogens
- (2008) Anne Davin-Regli et al. CURRENT DRUG TARGETS
- Potential of old-generation antibiotics to address current need for new antibiotics
- (2008) Matthew E Falagas et al. Expert Review of Anti-Infective Therapy
- Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities
- (2008) Marta Martins et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis
- (2008) L. Rodrigues et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli
- (2008) Minna Hannula et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement
- (2008) Ian Chopra et al. LANCET INFECTIOUS DISEASES
- The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
- (2008) Jean-Marie Pagès et al. NATURE REVIEWS MICROBIOLOGY
- Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics
- (2008) P. Natarajan et al. PHYTOMEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started